tiprankstipranks
Immupharma Announces Change in Major Shareholdings
Company Announcements

Immupharma Announces Change in Major Shareholdings

Story Highlights

Don't Miss Our Christmas Offers:

ImmuPharma ( (GB:IMM) ) has shared an update.

Immupharma PLC, a UK-based pharmaceutical company, has reported a change in its major shareholdings. Lanstead Capital Investors LP has reduced its stake in the company from 9.99% to 6.90%. This reduction in voting rights could potentially impact Immupharma’s shareholder dynamics and influence its future strategic decisions.

More about ImmuPharma

YTD Price Performance: -29.99%

Average Trading Volume: 1,288,133

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: £4.86M

See more data about IMM stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskImmuPharma Strengthens Financial Team with New Appointment
TipRanks UK Auto-Generated NewsdeskImmuPharma Appoints New Company Secretary for Strategic Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App